Interesting! [General Sta­tis­tics]

posted by GM – India, 2017-03-29 22:06 (2951 d 07:02 ago) – Posting: # 17209
Views: 9,913

Dear David,

❝ For the statistical evaluation of "difference in means", to be compared with the same statistical conclusion of "difference in means" with the 90% confidence interval, the p value must be assessed against the 10% significance level. So, if your 90% Confidence Interval does not contain 1, then the p-value for formulation is also significant at the 10% significance level and may or not be also significant at the 5% significance level.


As Helmut also told in the above discussion, generally we are assessing the treatment effect @5% significance level only.

But based on your statement, it is 10% level of significance. Now I am in confusion :confused:... whether 5% level or 10% level of significance we need to consider for BE...? Please clarify.

Thanks.
Regards,
GM

Best Regards,
GM

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
87 visitors (0 registered, 87 guests [including 6 identified bots]).
Forum time: 05:09 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5